Entering text into the input field will update the search result below

BeyondSpring Inc. (BYSI) CEO Dr. Lan Huang on Q4 2020 Results - Earnings Call Transcript

May 01, 2021 4:39 PM ETBeyondSpring Inc. (BYSI)
SA Transcripts profile picture
SA Transcripts

BeyondSpring Inc. (NASDAQ:BYSI) Q4 2020 Results Conference Call April 30, 2021 8:30 AM ET

Company Participants

Andrew Ericsson - Investor Relations

Dr. Lan Huang - Co-Founder, Chairwoman and Chief Executive Officer

Dr. Ramon Mohanlal - EVP, Research and Development and Chief Medical Officer

Richard Daly - Chief Operating Officer

Elizabeth Czerepak - Chief Financial Officer.

Conference Call Participants

Maury Raycroft - Jefferies

Jason Gerberry - Bank of America

Andy Hsieh - William Blair


Good morning, and welcome to BeyondSpring's Fourth Quarter and Full Year 2020 Financial Results Conference call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a brief question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded today, April 30, 2021.

I would now like to turn the conference over to Andrew Ericsson, Investor Relations. Please go ahead.

Andrew Ericsson

Thank you, everyone, for joining today's call. I'd like to advise listeners that comments made on today's call may reflect forward-looking statements that are related to such matters as BeyondSpring's clinical and preclinical research and development activities and results, regulatory and commercial plans, industry trends, market potential, collaborative initiatives and financial projections, among others.

While management believes that its assumptions, expectations and projections are reasonable in view of the currently available information, you are cautioned not to place undue reliance on these forward-looking statements. The Company's actual results may differ materially from those discussed during this call for a variety of reasons, including those described in the forward-looking statements and Risk Factors section of the Company's 20-F and other filings with the SEC, which are available on the Investors section of BeyondSpring's website.

Joining us on today's call is Dr. Lan Huang, BeyondSpring's Co-Founder, Chairwoman and Chief Executive Officer; Dr. Ramon Mohanlal; Executive Vice President, Research and Development and Chief Medical Officer; Richard Daly, Chief

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.